Skip to main content
Press release October 28, 2026

Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026

Kymera Therapeutics, Inc. (KYMR)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site